• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Understanding the needs of women considering risk-reducing salpingo-oophorectomy.了解考虑行预防性输卵管卵巢切除术的女性的需求。
Cancer Nurs. 2013 May-Jun;36(3):E33-8. doi: 10.1097/NCC.0b013e3182642cb5.
2
Surgical decision making in premenopausal carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study.考虑行预防性输卵管切除术或输卵管卵巢切除术降低风险的绝经前携带者的手术决策:一项定性研究。
J Med Genet. 2022 Feb;59(2):122-132. doi: 10.1136/jmedgenet-2020-107501. Epub 2021 Feb 10.
3
Salpingectomy With Delayed Oophorectomy in BRCA1/2 Mutation Carriers: Estimating Ovarian Cancer Risk.BRCA1/2 突变携带者行输卵管切除术并延迟卵巢切除术:评估卵巢癌风险
Obstet Gynecol. 2016 Jun;127(6):1054-1063. doi: 10.1097/AOG.0000000000001448.
4
Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.接受降低风险的输卵管卵巢切除术的女性隐匿性肿瘤的预测因素。
Am J Obstet Gynecol. 2006 Jun;194(6):1702-9. doi: 10.1016/j.ajog.2006.03.006.
5
Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.BRCA1/2 致病性变异携带者选择卵巢癌预防策略的患者决策辅助工具评估。
Gynecol Oncol. 2021 Nov;163(2):371-377. doi: 10.1016/j.ygyno.2021.08.019. Epub 2021 Aug 27.
6
Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.BRCA1 突变携带者行预防性输卵管卵巢切除术的经验及遗传性乳腺癌卵巢癌综合征预防性手术体系在日本的建立:我们未来的挑战。
Jpn J Clin Oncol. 2013 May;43(5):515-9. doi: 10.1093/jjco/hyt036. Epub 2013 Mar 13.
7
Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.预防性输卵管切除术和延迟卵巢切除术作为 BRCA 基因突变携带者的替代方案。
Obstet Gynecol. 2013 Jan;121(1):14-24. doi: 10.1097/aog.0b013e3182783c2f.
8
Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene.由于BRCA1或BRCA2基因的遗传性突变而进行预防性输卵管卵巢切除术后的乳腺癌和卵巢癌风险认知。
Clin Genet. 2009 Mar;75(3):220-4. doi: 10.1111/j.1399-0004.2008.01117.x.
9
Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.BRCA 携带者和未知突变状态女性行预防性输卵管卵巢切除术的结局。
BJOG. 2011 Jun;118(7):814-24. doi: 10.1111/j.1471-0528.2011.02920.x. Epub 2011 Mar 10.
10
Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: patients' and professionals' perspectives.BRCA1/2 基因突变携带者的预防性输卵管切除术联合延迟卵巢切除术:患者和专业人士的观点。
Gynecol Oncol. 2015 Feb;136(2):305-10. doi: 10.1016/j.ygyno.2014.12.031. Epub 2015 Jan 2.

引用本文的文献

1
Consumer-oriented (patient and family) outcomes from nursing in genomics: a scoping review of the literature (2012-2022).基因组学护理中以消费者为导向(患者及家属)的结果:文献综述(2012 - 2022年)
Front Genet. 2024 Nov 29;15:1481948. doi: 10.3389/fgene.2024.1481948. eCollection 2024.
2
Current State of Genomics in Nursing: A Scoping Review of Healthcare Provider Oriented (Clinical and Educational) Outcomes (2012-2022).当前护理基因组学的状况:以医疗保健提供者为导向的(临床和教育)结果的范围综述(2012-2022 年)。
Genes (Basel). 2023 Oct 27;14(11):2013. doi: 10.3390/genes14112013.
3
Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature.患者对降低卵巢癌风险的预防性输卵管切除术联合延迟卵巢切除术的看法:文献系统评价。
Gynecol Oncol. 2023 Jun;173:106-113. doi: 10.1016/j.ygyno.2023.04.006. Epub 2023 Apr 26.
4
The Psychosocial Impact of the Decision to Undergo Risk-Reducing Salpingo-Oophorectomy Surgery in Mutation Carriers and the Role of Physician-Patient Communication.携带基因突变者行预防性输卵管卵巢切除术的决策所带来的心理社会影响,以及医患沟通的作用。
Curr Oncol. 2023 Feb 17;30(2):2429-2440. doi: 10.3390/curroncol30020185.
5
Factors associated with the decision to undergo risk-reducing salpingo-oophorectomy among women at high risk for hereditary breast and ovarian cancer: a systematic review.遗传性乳腺癌和卵巢癌高危女性中与接受降低风险的输卵管卵巢切除术决策相关的因素:一项系统综述
Korean J Women Health Nurs. 2020 Dec 31;26(4):285-299. doi: 10.4069/kjwhn.2020.11.19. Epub 2020 Dec 9.
6
The needs of Southeast Asian BRCA mutation carriers considering risk-reducing salpingo-oophorectomy: a qualitative study.考虑行预防性输卵管卵巢切除术的东南亚 BRCA 突变携带者的需求:一项定性研究。
Fam Cancer. 2022 Jan;21(1):21-33. doi: 10.1007/s10689-021-00232-6. Epub 2021 Feb 19.
7
Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.高级别浆液性卵巢癌的肿瘤筛查、成像及虚拟替身技术进展
Front Oncol. 2014 Nov 18;4:322. doi: 10.3389/fonc.2014.00322. eCollection 2014.

本文引用的文献

1
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.BRCA1 或 BRCA2 基因突变携带者的降低风险手术与癌症风险和死亡率的关联。
JAMA. 2010 Sep 1;304(9):967-75. doi: 10.1001/jama.2010.1237.
2
Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.女性对考虑进行风险降低性乳房切除术和风险降低卵巢切除术的“最佳时机”的建构。
BMC Womens Health. 2010 Aug 5;10:24. doi: 10.1186/1472-6874-10-24.
3
Beliefs and beyond: what can we learn from qualitative studies of lay people's understandings of cancer risk?信念与超越:从定性研究中我们能了解到普通民众对癌症风险的哪些认知?
Health Expect. 2010 Jun;13(2):113-24. doi: 10.1111/j.1369-7625.2010.00601.x.
4
Genetic/familial high-risk assessment: breast and ovarian.遗传/家族性高风险评估:乳腺癌和卵巢癌。
J Natl Compr Canc Netw. 2010 May;8(5):562-94. doi: 10.6004/jnccn.2010.0043.
5
Women's decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review.遗传性乳腺癌和卵巢癌背景下女性关于降低风险策略的决策:一项系统综述
J Genet Couns. 2009 Dec;18(6):578-97. doi: 10.1007/s10897-009-9245-9. Epub 2009 Oct 3.
6
Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.在乳腺癌和卵巢癌高危的未患病女性中,接受降低风险手术的情况取决于风险、年龄和时间。
Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2318-24. doi: 10.1158/1055-9965.EPI-09-0171.
7
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.对BRCA1或BRCA2基因突变携带者行降低风险的输卵管卵巢切除术相关风险降低估计值的荟萃分析。
J Natl Cancer Inst. 2009 Jan 21;101(2):80-7. doi: 10.1093/jnci/djn442. Epub 2009 Jan 13.
8
A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.一项关于接受降低风险的输卵管卵巢切除术的女性与接受卵巢癌妇科筛查的女性生活质量的前瞻性研究。
Gynecol Oncol. 2009 Mar;112(3):594-600. doi: 10.1016/j.ygyno.2008.11.039. Epub 2009 Jan 13.
9
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.降低风险的输卵管卵巢切除术预防BRCA1和BRCA2相关乳腺癌及妇科癌症:一项多中心前瞻性研究
J Clin Oncol. 2008 Mar 10;26(8):1331-7. doi: 10.1200/JCO.2007.13.9626. Epub 2008 Feb 11.
10
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.携带BRCA1和BRCA2基因突变者预防性治疗方案的国际应用率差异
Int J Cancer. 2008 May 1;122(9):2017-22. doi: 10.1002/ijc.23340.

了解考虑行预防性输卵管卵巢切除术的女性的需求。

Understanding the needs of women considering risk-reducing salpingo-oophorectomy.

机构信息

Women's Cancer, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

出版信息

Cancer Nurs. 2013 May-Jun;36(3):E33-8. doi: 10.1097/NCC.0b013e3182642cb5.

DOI:10.1097/NCC.0b013e3182642cb5
PMID:22964868
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3637391/
Abstract

BACKGROUND

Because of the significantly increased lifetime risk of ovarian cancer associated with inheritance of a germline mutation in the BRCA1/2 genes, women with a deleterious mutation are recommended to undergo risk-reducing salpingo-oophorectomy at age 35 years or once child-bearing is complete. Significant time is often spent by nurses trained in genetics providing counseling to improve the decision-making process. The decision to undergo surgery is complex and laden with several sources of uncertainty.

OBJECTIVE

We conducted a qualitative study among female carriers of deleterious BRCA1/2 mutations to address these uncertainties.

METHODS

Twelve qualitative interviews were conducted with women who had received a positive BRCA1/2 test result to explore their understanding of ovarian cancer risk, prevention options, and resource needs. Qualitative content analysis was performed.

RESULTS

Significant information gaps in level of risk, other factors associated with ovarian cancer, and details of prophylactic oophorectomy were identified. Personal experience with cancer colored the degree of risk perception associated with the inherited mutation. Fear of the adverse effects of surgical menopause, both physiological and psychosocial, was common. Women expressed interest in hearing from other women facing the same decision.

CONCLUSIONS

Women facing the decision to undergo risk-reducing salpingo-oophorectomy have several information gaps and unmet needs despite comprehensive counseling.

IMPLICATIONS FOR PRACTICE

Based on our findings, we make specific recommendations that will guide nursing practice and future research.

摘要

背景

由于携带 BRCA1/2 基因种系突变会显著增加患卵巢癌的终身风险,因此建议携带有害突变的女性在 35 岁或完成生育后进行降低风险的输卵管卵巢切除术。接受过基因学培训的护士通常会花费大量时间提供咨询,以改善决策过程。手术的决定是复杂的,存在多种不确定性来源。

目的

我们对携带有害 BRCA1/2 突变的女性进行了定性研究,以解决这些不确定性。

方法

对 12 名接受阳性 BRCA1/2 检测结果的女性进行了定性访谈,以探讨她们对卵巢癌风险、预防选择和资源需求的理解。进行了定性内容分析。

结果

确定了风险水平、与卵巢癌相关的其他因素以及预防性卵巢切除术的详细信息方面存在显著的信息差距。个人患癌经历影响了对遗传性突变相关风险的感知程度。对手术性绝经的不良影响(生理和心理社会方面)的担忧很常见。女性表示有兴趣听取其他面临相同决策的女性的意见。

结论

尽管接受了全面咨询,但面临进行降低风险的输卵管卵巢切除术的女性仍存在多个信息差距和未满足的需求。

实践意义

基于我们的发现,我们提出了具体建议,将指导护理实践和未来的研究。